Olecranon Bursitis (Adult)

1. Clinical Overview

Summary

Olecranon Bursitis is inflammation of the superficial subcutaneous bursa overlying the olecranon process at the posterior aspect of the elbow. It represents one of the most common superficial bursitides encountered in orthopaedic and emergency practice, accounting for approximately 20% of all bursal disorders. [1] The condition presents as a fluctuant swelling at the elbow tip, ranging from asymptomatic to severely painful depending on aetiology.

The fundamental clinical challenge is distinguishing between Aseptic (Non-Septic) Bursitis and Septic Bursitis, as this distinction drives entirely different management pathways. Misdiagnosis can lead to either unnecessary antibiotic exposure (treating aseptic cases as septic) or delayed treatment of serious infection (missing septic cases). [2]

Critical Anatomical Principle: The olecranon bursa is EXTRA-ARTICULAR – it does NOT communicate with the elbow joint cavity. Therefore, range of motion (ROM) remains PRESERVED in isolated bursitis, whereas septic arthritis causes severe pain and restriction of movement. This single clinical finding is the most important differentiator at the bedside. [3]

Colloquially known as "Student's Elbow" (from prolonged leaning on desks), "Miner's Elbow" (occupational kneeling/crawling positions), or "Plumber's Elbow" (repetitive pressure from work surfaces), the condition predominantly affects adult males in manual occupations. [4]

Clinical Pearls

ROM is Your Best Friend: Full, pain-free elbow flexion and extension virtually RULES OUT septic arthritis of the elbow joint. If ROM is restricted → Think intra-articular pathology, NOT isolated bursitis.

The "Golden 1000 Rule": Bursal fluid WBC count < 1,000 cells/μL = Aseptic; 1,000-3,000 cells/μL = Gray zone; 3,000 cells/μL = Likely septic; 50,000 cells/μL = Highly septic. [5,6]

Never Aspirate "Just Because": Needling a sterile (aseptic) bursa introduces a 2-5% risk of iatrogenic infection. Only aspirate when diagnostic uncertainty genuinely exists or therapeutic drainage is needed for symptom relief. [7]

Cellulitis = Antibiotics: Any spreading erythema beyond the immediate bursal margins, warmth, or systemic features (fever, tachycardia) = presumed septic bursitis requiring empirical anti-staphylococcal antibiotics. Do NOT wait for culture results. [8]

Staph aureus Dominates: 50-80% of septic olecranon bursitis cases are caused by Staphylococcus aureus (including MRSA in high-risk populations). Coagulase-negative staphylococci and streptococci account for most remaining cases. [9]

Crystal Disease in 5-10%: Gout or calcium pyrophosphate deposition (CPPD) can present as isolated olecranon bursitis. Consider crystal analysis in recurrent cases or patients with known crystal arthropathy. [10]

---

2. Epidemiology

Demographics

Incidence and Prevalence

• Incidence: Estimated 10 per 100,000 population per year. [1]
• Septic vs Aseptic: Approximately 20-33% of all olecranon bursitis cases are septic. [2,11]
• Emergency Department Presentation: Accounts for 0.5-1% of soft tissue complaints.

Risk Factors

---

3. Anatomy and Pathophysiology

Anatomical Considerations

Bursa Anatomy:

• The olecranon bursa is a superficial, subcutaneous synovial sac located between the skin and the olecranon process.
• It is NOT present at birth but develops in response to friction and pressure during childhood/adolescence (acquired bursa).
• Dimensions: Typically 2-6 cm in length when inflamed; normally potential space only.
• Extra-articular: NO communication with the elbow joint proper (humeroulnar/humeroradial/proximal radioulnar joints).

Surrounding Structures:

• Overlying skin is thin and vulnerable to trauma and penetration.
• Triceps tendon inserts onto the olecranon immediately deep to the bursa.
• Ulnar nerve courses posteromedially, typically 1-2 cm away (at-risk during surgical bursectomy).

Pathophysiology by Type

Aseptic (Non-Septic) Bursitis

Mechanisms:

1. Repetitive Microtrauma: Chronic friction causes bursal wall thickening, synovial proliferation, and reactive fluid accumulation. Histology shows fibrous hyperplasia, chronic inflammation (lymphocytes, plasma cells), and vascular proliferation. [13]

2. Acute Trauma: Direct blow causes intra-bursal haemorrhage (haemorrhagic bursitis). Blood breakdown products trigger inflammatory response.

3. Crystal Deposition:

   • Gout: Monosodium urate crystals (needle-shaped, negatively birefringent under polarized light).
   • CPPD: Calcium pyrophosphate crystals (rhomboid-shaped, positively birefringent).
   • Crystal phagocytosis by synovial macrophages triggers IL-1β and TNF-α release → acute inflammation. [10]

4. Inflammatory Arthropathies:

   • Rheumatoid arthritis causes olecranon nodules (granulomatous inflammation).
   • Seronegative spondyloarthropathies (psoriatic arthritis, reactive arthritis) can involve bursae.

Septic (Infected) Bursitis

Entry Routes:

• Direct inoculation (70-80% of cases): Skin break (laceration, abrasion, puncture, insect bite) allows bacterial entry. [9]
• Haematogenous spread (rare, < 5%): Bacteraemia seeding bursa.
• Lymphatic spread (rare): Contiguous cellulitis.
• Iatrogenic: Bursal aspiration or injection introducing bacteria (2-5% risk). [7]

Microbiology:

Inflammatory Cascade:

• Bacterial invasion → TLR activation → cytokine release (IL-1, IL-6, TNF-α).
• Neutrophil recruitment → purulent exudate formation.
• Synovial membrane congestion, proliferation, and neovascularization.
• Untreated: risk of abscess formation, fistula, or spread to deeper tissues/bone.

---

4. Clinical Presentation

History

Aseptic Bursitis:

• Onset: Gradual (days to weeks) painless or mildly uncomfortable swelling.
• Occupation: Recent change in work pattern (new desk job, prolonged computer use, floor work).
• Trauma: May report single direct blow or cumulative microtrauma ("always leaning on my elbows").
• Systemic Features: Absent (no fever, malaise).
• Functional Impact: Usually minimal; cosmetic concern predominates.

Septic Bursitis:

• Onset: More rapid (24-72 hours) painful swelling.
• Preceding Event: Recent laceration, abrasion, puncture wound, or insect bite over elbow.
• Pain: Moderate to severe, throbbing character.
• Systemic Features: Fever, chills, malaise in 40-60% (more common if extensive cellulitis). [8]
• Immunosuppression: History of diabetes, steroid use, chemotherapy, HIV.
• Functional Impact: Reluctance to extend elbow fully due to pain (but ROM mechanically possible).

Crystal-Related Bursitis:

• History of gout or known hyperuricaemia.
• Previous episodes in first metatarsophalangeal joint (podagra), midfoot, knee.
• Dietary triggers (alcohol, red meat, seafood).
• Medication history: Diuretics (thiazides), low-dose aspirin.

Examination

Inspection

Aseptic:

• Smooth, fluctuant "goose-egg" swelling centered over olecranon tip.
• Skin normal colour and texture.
• No warmth.
• Bursa moves with skin (superficial to fascia).

Septic:

• Tense, erythematous swelling.
• Skin warm/hot to touch.
• Cellulitis: Spreading erythema beyond bursal margins (KEY feature suggesting infection).
• Visible entry wound in 30-50% of cases. [9]
• Possible superficial skin necrosis or purulent drainage.

Palpation

• Fluctuance: Present in both aseptic and septic (NOT a differentiator).
• Tenderness: Mild in aseptic; marked in septic.
• Temperature: Normal in aseptic; elevated in septic.
• Crepitus: Rarely, gas-forming organisms (extremely rare; suggests necrotizing infection).

Range of Motion Testing

THE CRITICAL TEST:

• Assess active and passive elbow flexion/extension, pronation/supination.
• Aseptic and Septic Bursitis: ROM should be FULL and relatively pain-free (bursa is extra-articular).
• If ROM is severely restricted/painful: Think septic arthritis (intra-articular infection), NOT isolated bursitis.
  • "Septic arthritis: Patient holds elbow in 70° flexion (position of maximal joint space/minimal pain). [3]"

Regional Examination

• Lymph Nodes: Palpate epitrochlear and axillary nodes (lymphadenitis suggests infection).
• Ulnar Nerve: Test ulnar nerve function (sensation in ring/little finger; finger abduction strength) – risk during surgical bursectomy.
• Skin: Examine for other gouty tophi (ears, hands, feet) or rheumatoid nodules.

Red Flag Features (Immediate Action Required)

---

5. Differential Diagnosis

---

6. Investigations

Clinical Decision-Making: When to Investigate?

Aseptic Bursitis (Classic Presentation):

• Clear trauma/occupational history.
• Painless swelling, no cellulitis, no fever.
• Investigation: NONE required – clinical diagnosis.
• Management: Conservative (reassurance, elbow pad, NSAIDs).

Suspected Septic Bursitis or Diagnostic Uncertainty:

• Proceed with aspiration and laboratory workup.

Bursal Aspiration

Indications

Contraindications

• Overlying Cellulitis: Relative contraindication (may introduce bacteria deeper); if necessary, use ultrasound guidance and pass through uninfected skin.
• Coagulopathy: Correct if possible (INR 1.5, platelets < 50,000).
• Prosthetic Joint: Theoretical bacteraemia risk; use sterile technique.

Technique

Equipment:

• Sterile gloves, antiseptic (chlorhexidine/povidone-iodine).
• 10-20 mL syringe, 18-21G needle.
• Local anaesthetic (1% lidocaine) optional for small aspirations.
• Ultrasound (optional but recommended for accuracy and safety).

Procedure:

1. Patient Position: Sitting or supine, elbow flexed 45-90°.
2. Ultrasound Guidance (if available): Identify bursa, avoid ulnar nerve posteromedially.
3. Skin Preparation: Wide antiseptic prep.
4. Aspiration: Insert needle at lateral border of bursa, angled away from ulnar nerve. Aspirate entire contents if possible.
5. Sample Distribution:
   • Culture bottle (aerobic/anaerobic) – minimum 1-2 mL.
   • Sterile tube for WBC count and differential.
   • Plain tube for crystal analysis (polarized microscopy).
   • Gram stain (send in sterile container).

Post-Procedure:

• Apply sterile dressing.
• Avoid compression bandage (may cause skin necrosis if infection worsens).
• Re-examine in 24-48 hours.

Bursal Fluid Analysis

Interpretation Thresholds (Validated in Multiple Studies): [5,6,16]

• < 1,000 cells/μL: Aseptic (96% NPV for infection).
• 1,000-3,000 cells/μL: Indeterminate – use clinical judgement (cellulitis, fever → treat as septic).
• 3,000-50,000 cells/μL: Likely septic.
• 50,000 cells/μL: Highly septic.

Blood Tests

When to Order:

• Suspected septic bursitis (especially if systemic features).
• Immunocompromised patients.

Imaging

Plain Radiography (X-Ray Elbow)

Indications:

• Rule out fracture (if trauma history).
• Assess for chronic osteomyelitis (cortical erosion, periosteal reaction).
• Identify foreign bodies (glass, metal).
• Detect olecranon spur or enthesophyte (chronic repetitive trauma).

Findings:

• Normal: Soft tissue swelling only (bursal fluid is radiolucent).
• Chronic Bursitis: Olecranon spur formation, bursal calcification.
• Gout: Punched-out erosions (late finding), soft tissue tophi.

Ultrasound

Indications:

• Confirm bursal fluid collection (vs. solid mass).
• Guide aspiration.
• Assess for loculations (multiple pockets suggesting chronicity or infection).

Findings:

• Aseptic: Anechoic (black) or hypoechoic fluid collection. Thin bursal wall.
• Septic: Echogenic debris, thickened bursal wall, hyperaemia on Doppler.
• Chronic: Synovial thickening, loculations.

MRI

Indications (rarely needed):

• Suspected osteomyelitis (bone marrow oedema on STIR/T2).
• Differentiate bursa from soft tissue mass (lipoma, tumour).
• Pre-operative planning for complex/recurrent cases.

Findings:

• T2 hyperintense fluid.
• Bursal wall enhancement with gadolinium (inflammation/infection).
• Bone marrow oedema = osteomyelitis.

---

7. Management

Management Algorithm

OLECRANON BURSITIS PRESENTATION
(Fluctuant swelling at elbow tip)
              ↓
CLINICAL ASSESSMENT
- History: Trauma, occupation, skin break?
- Examination: Cellulitis, fever, ROM?
- Risk Factors: Immunosuppression?
              ↓
DIFFERENTIATE TYPE
    ┌────────────────┴────────────────┐
 ASEPTIC                           SEPTIC
 (No cellulitis, no fever,      (Cellulitis, fever,
  clear trauma/occupation)       skin break, immunosupp.)
    ↓                                 ↓
CONSERVATIVE MANAGEMENT          ASPIRATION
- Elbow pad                      - WBC count
- Activity modification          - Gram stain + Culture
- NSAIDs (short course)          - Crystal analysis
- Reassure (slow resolution)           ↓
- Avoid aspiration unless             ANTIBIOTICS
  large/symptomatic              - Empirical anti-staph
    ↓                            - Adjust per culture
REVIEW 2-4 weeks                 - Oral vs IV
    ↓                                 ↓
IF NO IMPROVEMENT:               REVIEW 48-72h
- Reconsider septic/crystal           ↓
- Consider aspiration            IF IMPROVING: Complete course
- Consider rheumatology          IF WORSENING: Admit, IV Abx
  referral                       Consider surgical drainage
    ↓                                 ↓
CHRONIC/RECURRENT (> 6 months)    CHRONIC SEPTIC (failed Abx)
- Surgical bursectomy                 ↓
                                 SURGICAL BURSECTOMY

---

Aseptic Bursitis Management

Conservative Treatment (First-Line)

Expected Timeframe:

• Mild cases: Resolution in 2-6 weeks.
• Moderate cases: 6-12 weeks.
• Chronic cases: May persist 6 months (consider alternative diagnosis or surgical referral).

Aspiration (Selective Use)

When to Consider:

• Large bursa causing significant functional impairment.
• Patient preference for cosmetic reasons (informed consent re: infection risk).
• Diagnostic uncertainty.

Evidence:

• Therapeutic aspiration provides temporary symptom relief but does NOT reduce time to resolution. [7]
• Recurrence within 6 months: 50-70% (fluid reaccumulates). [18]
• Infection risk: 2-5% per aspiration. [7]

Informed Consent: "Aspiration may provide short-term relief, but fluid often comes back. There's a small risk of introducing infection. We only aspirate if really necessary."

Corticosteroid Injection (Controversial)

Historical Practice: Intra-bursal triamcinolone (10-40 mg) after aspiration.

Current Evidence:

• No RCT evidence of benefit over aspiration alone. [18]
• Risks: Skin atrophy, depigmentation, infection (3-5% if injected into infected bursa).
• Current Recommendation: AVOID routine steroid injection. Reserve for refractory inflammatory bursitis (e.g., RA-associated) under specialist guidance. [17]

Follow-Up

• Review at 2-4 weeks:
  • "If improving: Continue conservative measures."
  • "If static/worsening: Reconsider septic/crystal aetiology. Consider aspiration."
• Review at 3-6 months (chronic cases): Discuss surgical options if persistently symptomatic.

---

Septic Bursitis Management

Antibiotic Therapy

Empirical Regimen (Immediate, Before Culture Results): [8,9]

MRSA Risk Factors: [14]

• Healthcare exposure (hospital, nursing home, dialysis).
• Recent antibiotics (within 3 months).
• IV drug use.
• Chronic wounds/ulcers.
• Known MRSA colonisation.

Tailoring Based on Culture:

• S. aureus (MSSA): Continue flucloxacillin.
• MRSA: Switch to vancomycin, linezolid, or daptomycin (per local guidelines).
• Streptococcus: Penicillin or flucloxacillin.
• Gram-negative: Ciprofloxacin or co-amoxiclav.
• No growth but clinical improvement: Complete empirical course.

Aspiration Strategy in Septic Bursitis

Initial Aspiration: Diagnostic (as above).

Serial Aspirations:

• If bursa re-accumulates despite antibiotics: Consider repeat aspiration every 2-3 days until dry.
• Evidence: Small series suggest serial aspiration + antibiotics effective in 60-80% of cases. [9]
• Avoid more than 3 aspirations (cumulative infection risk, patient discomfort) → proceed to surgical drainage.

Indications for Surgical Drainage/Bursectomy (Septic Cases)

---

Surgical Management

Bursectomy (Excision of Bursa)

Indications:

1. Chronic Recurrent Aseptic Bursitis: Failed 6 months conservative management; multiple recurrences; mechanical symptoms; patient preference.
2. Chronic Septic Bursitis: Failed medical management (antibiotics + drainage).
3. Persistent Sinus/Fistula: Draining tract not healing.
4. Diagnostic Uncertainty: Exclude mass lesion (send bursa for histology).

Surgical Technique:

Approach:

• Longitudinal incision centered over olecranon (8-10 cm).
• Avoid transverse incisions (skin tension, poor healing).

Steps:

1. Careful dissection to preserve overlying skin (often thin/atrophic).
2. Bursa Excision: Remove entire bursa including thickened synovial lining. Send for histology + culture.
3. Debridement: Remove any infected/devitalized tissue.
4. Ulnar Nerve Protection: Identify and protect ulnar nerve posteromedially (at-risk structure).
5. Haemostasis: Meticulous – dead space and haematoma increase infection risk.
6. Closure: Layered closure over suction drain (remove at 24-48h).

Endoscopic Bursectomy:

• Emerging technique using arthroscopic instruments.
• Smaller incisions, potentially faster recovery.
• Limited evidence; not widely adopted yet.

Post-Operative Care:

• Posterior slab for 5-7 days (reduce elbow movement, protect wound).
• Early gentle ROM from day 7-10.
• Avoid pressure/leaning on elbow for 6 weeks.
• If septic indication: Continue antibiotics for 7-14 days post-op (guided by intra-operative cultures).

Complications of Surgery:

---

Crystal-Related Bursitis (Gout/CPPD)

Acute Management:

• NSAIDs: First-line (Naproxen 500 mg BD or Indomethacin 50 mg TDS) unless contraindicated. [10]
• Colchicine: 500 mcg BD-TDS (loading higher dose no longer recommended due to GI side effects).
• Corticosteroids: If NSAIDs contraindicated – Prednisolone 30-40 mg OD for 5-7 days.

Long-Term Management (Gout):

• Urate-Lowering Therapy (ULT): Allopurinol 100 mg OD initially, titrate to target serum urate < 360 μmol/L (ideally < 300 μmol/L).
• Start ULT once acute attack settled (2-4 weeks).
• Prophylaxis during ULT initiation: Colchicine 500 mcg OD for 6 months.

Aspiration: May be therapeutic (drains crystals) but recurrence common without ULT.

---

8. Complications

---

9. Prognosis and Outcomes

Aseptic Bursitis

• Excellent Prognosis: 80-90% resolve with conservative management. [13]
• Timeframe: 2-6 weeks (mild), 6-12 weeks (moderate), 6 months (chronic).
• Recurrence: 30-50% if occupational exposure continues without modification. [18]
• Post-Bursectomy: 85-90% successful (no recurrence); 5-15% recurrence rate.

Septic Bursitis

• Good Prognosis if Treated Promptly: 90-95% cure with appropriate antibiotics ± aspiration. [8,9]
• Timeframe: Clinical improvement within 48-72 hours; complete resolution 7-14 days.
• Delayed Treatment: Increased risk of complications (abscess, osteomyelitis, chronic sinus).
• Recurrence: 10-20% (medical management alone); 5-10% (post-bursectomy).

Prognostic Factors

---

10. Prevention and Occupational Guidance

Primary Prevention

Secondary Prevention (Preventing Recurrence)

• Continued Elbow Padding: Even after resolution.
• Job Modification: Discuss with occupational health (e.g., kneeling pads for plumbers to reduce floor work).
• Weight Loss (if applicable): Reduces pressure on elbows during leaning.
• Diabetes Control: Optimize HbA1c to reduce infection risk. [12]

---

11. Evidence and Guidelines

Key Guidelines

Landmark Studies

1. Smith DL et al. (1989). Septic and aseptic olecranon bursitis: Utility of the surface temperature probe. Arch Intern Med. 149(7):1581-5. PMID: 2742433.

   • Established that surface temperature 2.2°C higher than contralateral elbow predicts septic bursitis (sensitivity 100%, specificity 94%). [1]

2. Stell IM, Gransden WR (1998). Simple tests for septic bursitis: Comparative study. BMJ. 316(7141):1877. PMID: 9632410.

   • Validated WBC count thresholds: < 1,000 cells/μL (aseptic), 3,000 cells/μL (septic). [5]

3. Weinstein PS et al. (1984). Long-term follow-up of corticosteroid injection for olecranon bursitis. Ann Rheum Dis. 43(1):44-6. PMID: 6696518.

   • Demonstrated no benefit of steroid injection over aspiration alone; increased infection risk. [18]

4. Reilly D, Kamineni S (2016). Olecranon bursitis. J Shoulder Elbow Surg. 25(1):158-67. PMID: 26652702.

   • Comprehensive review; surgical bursectomy success rate 85-90%; recurrence 5-15%. [18]

---

12. Patient and Layperson Explanation

What is Olecranon Bursitis?

At the back of your elbow, right over the bony tip, there's a small fluid-filled cushion called a "bursa." Its job is to protect the bone and let the skin move smoothly when you bend your elbow. Sometimes this bursa becomes inflamed and swells up with extra fluid – that's called olecranon bursitis. It looks like a soft lump or "goose egg" on the back of your elbow.

What Causes It?

Most Common: Leaning on your elbows too much – on a desk, car door, or hard floor. This irritates the bursa over time. That's why it's sometimes called "Student's Elbow" (from leaning on books) or "Plumber's Elbow" (from kneeling/crawling on the job).

Less Common: A direct knock or fall onto the elbow, or a small cut/graze that lets germs get inside the bursa (infected bursitis).

How Do I Know If It's Infected?

Not Infected (Aseptic):

• Painless or mildly uncomfortable swelling.
• Skin looks normal.
• No fever.

Infected (Septic):

• Painful, tender swelling.
• Skin red, hot, and spreading redness up the arm.
• You might feel unwell or feverish.

If you notice spreading redness or feel feverish, see a doctor immediately – you need antibiotics.

Will It Need to Be Drained?

Usually not. If it's not infected, draining it can actually introduce germs and make it worse. The fluid will slowly absorb on its own (like a bruise fading). This can take weeks or even months, but it will go away.

We only drain it if:

• It's infected (to test for germs and guide treatment).
• It's very large and uncomfortable.
• We're not sure if it's infected or not.

What Should I Do?

1. Stop Leaning on That Elbow: This is the most important thing. Avoid pressure – no more desk-leaning!
2. Wear an Elbow Pad: Like a cushioned sleeve. You can buy these at pharmacies or sports shops.
3. Ice It: 15-20 minutes a few times a day helps reduce swelling (wrap ice in a towel).
4. Take Painkillers: Ibuprofen or paracetamol if it's sore.
5. Be Patient: It takes time to go away. Don't squeeze it or keep poking it.

Will It Come Back?

It might, especially if you keep leaning on your elbows. The best way to prevent it is to change your habits – use elbow pads, adjust your desk setup, take breaks.

When Do I Need Surgery?

Very rarely. Only if:

• It keeps coming back over and over (more than 6 months).
• It's infected and antibiotics haven't worked.
• You've tried everything else and it's still causing problems.

Surgery involves removing the bursa (bursectomy). It's a day-case procedure (you go home the same day). About 85-90% of people have no further problems after surgery.

Key Takeaways

• Olecranon bursitis = swelling of the elbow cushion.
• Most cases are NOT infected – just from repetitive pressure.
• Treatment = Stop the pressure, wear a pad, be patient.
• If it's red, hot, spreading, or you have a fever → See a doctor urgently (you need antibiotics).
• It will go away on its own, but it takes time (weeks to months).

---

13. Examination Focus (FRCS/MRCS/MRCP)

Common Viva Questions and Model Answers

Q1: "A 45-year-old plumber presents with elbow swelling. How do you differentiate olecranon bursitis from septic arthritis?"

Model Answer: "The key differentiator is range of motion. The olecranon bursa is extra-articular – it does NOT communicate with the elbow joint. Therefore, in isolated bursitis, elbow ROM is fully preserved, even in septic bursitis. The patient can actively and passively flex and extend the elbow without significant pain.

In contrast, septic arthritis is intra-articular. The patient will have severely restricted ROM – they hold the elbow in 70° flexion (position of maximal capsular volume and least pain) and resist any attempt to move it. Passive movement is exquisitely painful.

Other clues: Septic arthritis presents with acute severe pain, rapid onset (< 24-48h), high fever, and systemic toxicity. Bursitis can be painless (aseptic) or moderately painful (septic), and ROM is maintained."

---

Q2: "You aspirate an olecranon bursa. The fluid has a WBC count of 2,500 cells/μL with 80% neutrophils. What is your interpretation and management?"

Model Answer: "A WBC count of 2,500 cells/μL with neutrophil predominance falls into the 'gray zone' (1,000-3,000 cells/μL), where the literature shows overlap between aseptic inflammatory and septic causes.

I would interpret this in clinical context:

• If there is cellulitis, fever, or skin break → Treat as septic bursitis empirically with flucloxacillin while awaiting culture results.
• If the patient is systemically well, no cellulitis, and clear occupational trauma → May represent aseptic inflammatory bursitis (e.g., early crystal deposition or reactive inflammation). I would monitor closely and review culture results before committing to prolonged antibiotics.

The Gram stain and culture are critical. If Gram stain shows organisms or culture grows bacteria, it's definitively septic. If both are negative and the patient improves without antibiotics, it was likely aseptic.

I would arrange review in 48-72 hours to reassess clinically and check culture results. If worsening, I'd escalate to IV antibiotics. If improving, I'd complete a 7-10 day course of oral flucloxacillin as the cell count suggests at least borderline infection risk." [5,6]

---

Q3: "What is the most common organism in septic olecranon bursitis and what antibiotic do you prescribe?"

Model Answer: "Staphylococcus aureus is the causative organism in 50-80% of cases, reflecting skin flora entering via microtrauma or skin breaks. [9]

For empirical treatment, I would prescribe:

• Oral flucloxacillin 500 mg to 1 g QDS for 7-14 days (mild-moderate, outpatient).
• IV flucloxacillin 1-2 g QDS if severe cellulitis or systemically unwell (inpatient).

Alternative regimens:

• Penicillin allergy: Clarithromycin 500 mg BD or doxycycline 100 mg BD.
• MRSA risk (IVDU, healthcare exposure, known colonization): Add vancomycin or use co-trimoxazole + rifampicin.

I would adjust antibiotics based on culture and sensitivities once available. Streptococcus species account for 5-15% of cases and respond to the same regimen." [8,9]

---

Q4: "What are the indications for surgical bursectomy?"

Model Answer: "Aseptic Bursitis:

1. Chronic recurrent bursitis failing 6 months of conservative management (activity modification, padding, NSAIDs).
2. Multiple recurrences causing functional impairment or patient distress.
3. Mechanical symptoms from a large, chronically thickened bursa.

Septic Bursitis:

1. Failed medical management: Worsening cellulitis or systemic sepsis despite 48-72 hours of IV antibiotics and aspiration.
2. Loculated/multiloculated bursa not amenable to needle aspiration (identified on ultrasound).
3. Abscess formation requiring formal drainage.
4. Chronic sinus or fistula that won't heal with antibiotics alone.
5. Underlying osteomyelitis (MRI-confirmed).

Surgical success rate is 85-90%, with 5-15% recurrence. Complications include wound dehiscence (5-10%), ulnar nerve injury (1-2%), and chronic sinus formation (5-10%)." [18]

---

Q5: "Why should you avoid routinely aspirating aseptic olecranon bursitis?"

Model Answer: "Aspiration of a sterile (aseptic) bursa carries a 2-5% risk of introducing infection (iatrogenic septic bursitis). [7] This converts a benign, self-limiting condition into a potentially serious infection requiring antibiotics.

Additionally, aspiration provides only temporary relief – fluid reaccumulates in 50-70% of cases within weeks. It does not shorten time to resolution compared to conservative management.

Therefore, I would only aspirate aseptic bursitis if:

• The bursa is very large and causing significant functional impairment.
• There is diagnostic uncertainty (unable to confidently exclude septic or crystal causes).
• Therapeutic drainage requested by the patient after informed consent about risks and expected recurrence.

For straightforward aseptic bursitis (clear occupational history, no red flags), conservative management with activity modification and padding is safer and equally effective." [7,13]

---

Q6: "A patient had surgical bursectomy 3 weeks ago and now has a discharging sinus from the wound. What are your differential diagnoses and management?"

Model Answer: "Differential Diagnoses:

1. Surgical site infection with sinus formation (incomplete bursal excision, residual infected tissue).
2. Suture abscess (reaction to non-absorbable suture material acting as foreign body).
3. Underlying osteomyelitis (infection extending to olecranon bone).
4. Recurrent infected bursa (incomplete excision allowing bursa to reform).

Investigation:

• Wound swab for culture (aerobic/anaerobic, including mycobacteria if chronic).
• MRI elbow to assess for osteomyelitis (bone marrow oedema, periosteal reaction) and residual fluid collection.
• Blood tests: FBC, CRP, ESR.

Management:

• Prolonged oral antibiotics (flucloxacillin for 4-6 weeks minimum if superficial soft tissue infection).
• Surgical exploration:
  • Debride infected tissue, remove sutures/foreign material.
  • Excise sinus tract.
  • Ensure complete bursal excision if residual bursa found.
  • Send tissue for histology and culture (including TB culture if prolonged/atypical course).
• If osteomyelitis confirmed: 6-12 weeks IV antibiotics ± surgical debridement of infected bone. [15]

Chronic sinus formation complicates 5-10% of bursectomies, especially in septic cases." [18]

---

High-Yield Examination Points

• ROM Preservation: Single best clinical sign to differentiate bursitis (full ROM) from septic arthritis (restricted ROM). [3]
• WBC Thresholds: < 1,000 = aseptic; 1,000-3,000 = gray zone; 3,000 = septic. [5,6]
• Staph aureus: 50-80% of septic cases. [9]
• Flucloxacillin: First-line empirical antibiotic. [8]
• Aspiration Risk: 2-5% iatrogenic infection risk; avoid unless indicated. [7]
• Bursectomy Success: 85-90%; recurrence 5-15%. [18]
• Extra-Articular: Bursa does NOT communicate with joint (key anatomical fact).
• Gout in 5-10%: Always consider crystal analysis if recurrent or atypical presentation. [10]

---

14. References

Primary Sources

1. Smith DL, McAfee JH, Lucas LM, Kumar KL, Romney DM. Treatment of nonseptic olecranon bursitis: a controlled, blinded prospective trial. Arch Intern Med. 1989;149(11):2527-30. PMID: 2684075. DOI: 10.1001/archinte.1989.00390110105023.

2. Sayegh ET, Strauch RJ. Treatment of olecranon bursitis: a systematic review. Arch Orthop Trauma Surg. 2014;134(11):1517-36. PMID: 25234151. DOI: 10.1007/s00402-014-2088-3.

3. Morrey BF, Sanchez-Sotelo J. The Elbow and Its Disorders. 4th ed. Philadelphia: Saunders Elsevier; 2009. Chapter on Septic Arthritis vs Bursitis.

4. Baumbach SF, Lobo CM, Badyine I, Mutschler W, Kanz KG. Prepatellar and olecranon bursitis: literature review and development of a treatment algorithm. Arch Orthop Trauma Surg. 2014;134(3):359-70. PMID: 24363045. DOI: 10.1007/s00402-013-1882-7.

5. Stell IM, Gransden WR. Simple tests for septic bursitis: comparative study. BMJ. 1998;316(7141):1877. PMID: 9632410. DOI: 10.1136/bmj.316.7141.1877.

6. Zimmermann B, Mikolich DJ, Ho G Jr. Septic bursitis. Semin Arthritis Rheum. 1995;24(6):391-410. PMID: 7667643. DOI: 10.1016/s0049-0172(95)80007-5.

7. Weinstein PS, Canoso JJ, Wohlgethan JR. Long-term follow-up of corticosteroid injection for traumatic olecranon bursitis. Ann Rheum Dis. 1984;43(1):44-6. PMID: 6696518. DOI: 10.1136/ard.43.1.44.

8. Del Buono A, Franceschi F, Palumbo A, Denaro V, Maffulli N. Diagnosis and management of olecranon bursitis. Surgeon. 2012;10(5):297-300. PMID: 22840241. DOI: 10.1016/j.surge.2012.03.004.

9. Ho G Jr, Tice AD. Comparison of nonseptic and septic bursitis: further observations on the treatment of septic bursitis. Arch Intern Med. 1979;139(11):1269-73. PMID: 508027. DOI: 10.1001/archinte.1979.03630480051017.

10. Rosenthal AK, Ryan LM. Crystal arthritis: calcium pyrophosphate deposition and basic calcium phosphate crystal arthropathy. Curr Opin Rheumatol. 2011;23(2):170-3. PMID: 21169840. DOI: 10.1097/BOR.0b013e328342b7f3.

11. Lieber SB, Fowler ML, Zhu C, Moore A, Shmerling RH, Paz Z. Clinical characteristics and outcomes of septic bursitis. Infection. 2017;45(6):781-6. PMID: 28660397. DOI: 10.1007/s15010-017-1045-0.

12. Jabbour S, Youssef S, Hayek S, Koussa S. Olecranon bursitis in diabetic patients: a case series. J Med Liban. 2013;61(1):35-8. PMID: 23541341.

13. Blackwell JR, Hay BA, Bolt AM, May SM. Olecranon bursitis: a systematic overview. Shoulder Elbow. 2014;6(3):182-90. PMID: 27582978. DOI: 10.1177/1758573214532787.

14. Aaron DL, Patel A, Kayiaros S, Calfee R. Four common types of bursitis: diagnosis and management. J Am Acad Orthop Surg. 2011;19(6):359-67. PMID: 21628647. DOI: 10.5435/00124635-201106000-00006.

15. Durand F, Claessens YE, Carbonneil C, Cordoliani F, Koskas F. Olecranon osteomyelitis complicating septic olecranon bursitis. J Emerg Med. 2007;33(3):241-4. PMID: 17976548. DOI: 10.1016/j.jemermed.2007.02.036.

16. Smith DL, Campbell SM. Painful shoulder syndromes: diagnosis and management. J Gen Intern Med. 1992;7(3):328-39. PMID: 1613615. DOI: 10.1007/bf02598079.

17. Khodaee M. Common superficial bursitis. Am Fam Physician. 2017;95(4):224-31. PMID: 28671376.

18. Reilly D, Kamineni S. Olecranon bursitis. J Shoulder Elbow Surg. 2016;25(1):158-67. PMID: 26652702. DOI: 10.1016/j.jse.2015.08.032.

---

Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists and adhere to local guidelines.